Comparing Automated Insulin Delivery and IV Insulin for Blood Sugar Control During Labor in Pregnant People with Type 1 Diabetes

What this Trial Is About

This clinical trial is studying pregnant people with type 1 diabetes to see if automated insulin delivery AID systems can better manage blood sugar during labor and delivery compared to the current standard, intravenous IV insulin. The study focuses on neonatal blood sugar outcomes, patient satisfaction with birth, and specific glucose control measures like time-in-range during labor. Participants are randomly assigned to either use an AID system or receive IV insulin. The AID system uses data from a continuous glucose monitor to automatically adjust insulin delivery based on predicted glucose levels and other factors. IV insulin is given continuously with manual adjustments following hospital protocols. This study compares these two methods during labor and delivery. During the study, researchers will collect data on the newborns first glucose level within two hours of birth and assess mothers satisfaction within two weeks after delivery using a birth satisfaction scale. Continuous glucose monitoring data will be analyzed from admission to the labor and delivery unit until the infant is born. Participants will be monitored closely to evaluate glucose control and safety throughout labor and delivery.

Automated Insulin for Management of Intrapartum Glycemia